Newbridge Financial Services Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3K | Sell |
|
|||||
|
2025
Q1 | $48.8K | Buy |
|
|||||
|
2024
Q4 | $53.4K | Sell |
|
|||||
|
2024
Q3 | $159K | Buy |
|
|||||
|
2024
Q2 | $148K | Sell |
|
|||||
|
2024
Q1 | $138K | Buy |
|
|||||
|
2023
Q4 | $89.6K | Sell |
|
|||||
|
2023
Q3 | $92.2K | Sell |
|
|||||
|
2023
Q2 | $97.7K | Sell |
|
|||||
|
2023
Q1 | $133K | Hold |
|
|||||
|
2022
Q4 | $117K | Sell |
|
|||||
|
2022
Q3 | $132K | Sell |
|
|||||
|
2022
Q2 | $118K | Sell |
|
|||||
|
2022
Q1 | $214K | Buy |
|
|||||
|
2021
Q4 | $80K | Buy |
|
|||||
|
2021
Q3 | $56K | Sell |
|
|||||
|
2021
Q2 | $554K | Sell |
|
|||||
|
2021
Q1 | $657K | Sell |
|
|||||
|
2020
Q4 | $693K | Buy |
|
|||||
|
2020
Q3 | $674K | Buy |
|